Reason for request

Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.

-


Clinical Benefit

Low

The actual benefit of BRONCHITOL is low.


Clinical Added Value

no clinical added value

BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis.


Contact Us

Évaluation des médicaments

See also